All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-33892628
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 33892628 A265V
IN
gag-pol
HIV Infections
D
G
S
L
View
2 33892628 D232N
IN
gag-pol
HIV Infections
D
G
S
L
View
3 33892628 E11D
IN
gag-pol
HIV Infections
D
G
S
L
View
4 33892628 E157Q
IN
gag-pol
HIV Infections
D
G
S
L
View
5 33892628 G134N
IN
gag-pol
HIV Infections
D
G
S
L
View
6 33892628 G149A
IN
gag-pol
HIV Infections
D
G
S
L
View
7 33892628 I135V
IN
gag-pol
HIV Infections
D
G
S
L
View
8 33892628 I72V
IN
gag-pol
HIV Infections
D
G
S
L
View
9 33892628 K136K
IN
gag-pol
HIV Infections
D
G
S
L
View
10 33892628 K136Q
IN
gag-pol
HIV Infections
D
G
S
L
View
11 33892628 K14R
IN
gag-pol
HIV Infections
D
G
S
L
View
12 33892628 L101I
IN
gag-pol
HIV Infections
D
G
S
L
View
13 33892628 L234I
IN
gag-pol
HIV Infections
D
G
S
L
View
14 33892628 L74I
IN
gag-pol
HIV Infections
D
G
S
L
View
15 33892628 L74M
IN
gag-pol
HIV Infections
D
G
S
L
View
16 33892628 L74V
IN
gag-pol
HIV Infections
D
G
S
L
View
17 33892628 M50I
IN
gag-pol
HIV Infections
D
G
S
L
View
18 33892628 N155H
IN
gag-pol
HIV Infections
D
G
S
L
View
19 33892628 P145S
IN
gag-pol
HIV Infections
D
G
S
L
View
20 33892628 Q148H
IN
gag-pol
HIV Infections
D
G
S
L
View
21 33892628 Q95K
IN
gag-pol
HIV Infections
D
G
S
L
View
22 33892628 R263K
IN
gag-pol
HIV Infections
D
G
S
L
View
23 33892628 R269K
IN
gag-pol
HIV Infections
D
G
S
L
View
24 33892628 S119R
IN
gag-pol
HIV Infections
D
G
S
L
View
25 33892628 S283G
IN
gag-pol
HIV Infections
D
G
S
L
View
26 33892628 T112V
IN
gag-pol
HIV Infections
D
G
S
L
View
27 33892628 T124A
IN
gag-pol
HIV Infections
D
G
S
L
View
28 33892628 T206S
IN
gag-pol
HIV Infections
D
G
S
L
View
29 33892628 T218I
IN
gag-pol
HIV Infections
D
G
S
L
View
30 33892628 T66A
IN
gag-pol
HIV Infections
D
G
S
L
View
31 33892628 T97A
IN
gag-pol
HIV Infections
D
G
S
L
View
32 33892628 V201I
IN
gag-pol
HIV Infections
D
G
S
L
View
33 33892628 V31I
IN
gag-pol
HIV Infections
D
G
S
L
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.